El 76 %
de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor.
Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El 76 %
de inversores minoristas pierde dinero al operar CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
El 76 %
de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor.
Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El 76 %
de inversores minoristas pierde dinero al operar CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
3i Group PLC
Cerrado
SectorÍndices
4,151 -0.05
Resumen
Variación precio
24h
Mínimo
4049
Máximo
4186
Ingresos | 2B |
|---|---|
Ventas | 2B |
P/B Media del Sector | 7.72 27.283 |
BPA | 2.12 |
Rentabilidad por dividendo | 1.8 |
Margen de beneficios | 100.196 |
Empleados | 223 |
EBITDA | 2B |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +8.53% upside |
Rentabilidad por dividendo Media del Sector | 1.80% 3.47% |
|---|
Capitalización Mercado | 926M 39B |
|---|---|
Apertura anterior | 4151.05 |
Cierre anterior | 4151 |
Noticias sobre sentimiento de mercado
By Acuity
42%
58%
9 / 30 Clasificación en Indices
3i Group PLC Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
3i Group PLC previsión
Precio Objetivo
By TipRanks
8.53% repunte
Estimación a 12 Meses
Media 4,490.83 GBX 8.53%
Máximo 5,000 GBX
Mínimo 3,600 GBX
De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para 3i Group PLC Dist en los últimos 3 meses.
Sentimiento
By Acuity
9 / 30 Clasificación en Índices
Noticias sobre sentimiento de mercado
Coyuntura alcista
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de 3i Group PLC
3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl